Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
132783,RSRCH,"Bayer HealthCare LLC",NJ,100000005409,17482.96,09/12/2014,RSRCH,205825890
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,14317.00,12/10/2014,GNRL,153121601
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,9722.31,12/10/2014,GNRL,153121578
132783,RSRCH,"Bayer HealthCare LLC",NJ,100000005409,7206.08,09/12/2014,RSRCH,205825184
132783,RSRCH,"Bayer HealthCare LLC",NJ,100000005409,4860.00,04/09/2014,RSRCH,205839118
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,4800.00,10/07/2015,GNRL,246017546
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,4500.00,10/24/2015,GNRL,310342246
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,4300.00,03/04/2015,GNRL,260028704
132783,RSRCH,"Bayer HealthCare LLC",NJ,100000005409,4050.00,04/09/2014,RSRCH,205836988
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,4000.00,10/22/2015,GNRL,290626510
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3750.00,11/20/2013,GNRL,104482766
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3750.00,03/15/2015,GNRL,260076044
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3400.00,09/08/2014,GNRL,196536796
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3400.00,06/20/2014,GNRL,196536818
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3400.00,07/29/2014,GNRL,196536810
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,3200.00,08/26/2014,GNRL,188042724
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,3200.00,02/19/2014,GNRL,187776134
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,3200.00,11/18/2015,GNRL,246017508
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,3200.00,06/24/2015,GNRL,246017538
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,3200.00,10/21/2015,GNRL,246017550
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,3200.00,01/07/2015,GNRL,332309635
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,3200.00,02/17/2015,GNRL,332356459
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,3200.00,04/14/2015,GNRL,332297041
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,3000.00,05/07/2014,GNRL,164552628
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,3000.00,02/09/2014,GNRL,164830576
132783,GNRL,"Covidien Sales LLC",MA,100000000098,2800.00,11/13/2013,GNRL,31676397
132783,GNRL,"Covidien Sales LLC",MA,100000000098,2800.00,10/06/2014,GNRL,222035932
132783,GNRL,"Covidien Sales LLC",MA,100000000098,2800.00,01/06/2014,GNRL,222035944
132783,GNRL,"Medtronic Vascular, Inc.",MN,100000010384,2800.00,07/29/2015,GNRL,296920146
132783,GNRL,"Medtronic Vascular, Inc.",MN,100000010384,2800.00,07/17/2015,GNRL,296297386
132783,GNRL,"Covidien Sales LLC",MA,100000000098,2800.00,01/14/2015,GNRL,295144728
132783,GNRL,"The Medicines Company",NJ,100000010428,2750.00,10/11/2015,GNRL,337737764
132783,GNRL,"LILLY USA, LLC",IN,100000000066,2700.00,11/15/2013,GNRL,100181972
132783,GNRL,"LILLY USA, LLC",IN,100000000066,2700.00,11/14/2013,GNRL,100180838
132783,GNRL,"LILLY USA, LLC",IN,100000000066,2700.00,09/25/2013,GNRL,100180840
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2700.00,05/31/2014,GNRL,196536924
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,2560.00,12/17/2014,GNRL,153121606
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,2560.00,12/10/2014,GNRL,153121596
132783,GNRL,"Pfizer Inc.",NY,100000000286,2500.00,10/27/2013,GNRL,206077822
132783,GNRL,"Pfizer Inc.",NY,100000000286,2500.00,11/05/2014,GNRL,207098460
132783,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,2500.00,12/14/2015,GNRL,263310370
132783,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,2500.00,11/18/2015,GNRL,263310382
132783,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,2500.00,11/04/2015,GNRL,263310386
132783,RSRCH,"Bayer HealthCare LLC",NJ,100000005409,2500.00,06/09/2014,RSRCH,205839378
132783,GNRL,"Covidien Sales LLC",MA,100000000098,2450.00,04/07/2014,GNRL,222035934
132783,GNRL,"Covidien Sales LLC",MA,100000000098,2450.00,06/30/2014,GNRL,222035942
132783,RSRCH,"Bayer HealthCare LLC",NJ,100000005409,2430.00,10/20/2014,RSRCH,205819827
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2400.00,07/15/2014,GNRL,196536804
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2400.00,07/23/2014,GNRL,196536812
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2400.00,10/29/2014,GNRL,196011846
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2400.00,12/02/2015,GNRL,290626518
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2400.00,12/02/2015,GNRL,290626520
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2400.00,06/26/2015,GNRL,290626528
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,2150.00,11/25/2013,GNRL,12196657
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,2150.00,09/10/2013,GNRL,12208432
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,2150.00,05/14/2014,GNRL,150031908
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,2150.00,06/18/2015,GNRL,260113496
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2050.00,12/17/2013,GNRL,104481858
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,2000.00,12/12/2013,GNRL,100721636
132783,GNRL,"Pfizer Inc.",NY,100000000286,2000.00,10/10/2013,GNRL,205076410
132783,GNRL,"Pfizer Inc.",NY,100000000286,2000.00,10/10/2013,GNRL,205206596
132783,GNRL,"Pfizer Inc.",NY,100000000286,2000.00,11/26/2013,GNRL,205662100
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,2000.00,02/18/2014,GNRL,164552820
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,2000.00,07/28/2014,GNRL,164552823
132783,GNRL,"Pfizer Inc.",NY,100000000286,2000.00,11/10/2014,GNRL,206855624
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,2000.00,04/25/2015,GNRL,312643856
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,2000.00,10/08/2015,GNRL,312643870
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,2000.00,09/10/2015,GNRL,312643878
132783,RSRCH,"Bayer HealthCare LLC",NJ,100000005409,1890.00,09/22/2014,RSRCH,205837042
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1600.00,11/25/2013,GNRL,12219409
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1600.00,09/25/2013,GNRL,12195294
132783,RSRCH,"Bayer HealthCare LLC",NJ,100000005409,1500.00,06/09/2014,RSRCH,205828080
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,1485.00,02/09/2014,GNRL,164853832
132783,RSRCH,"Bayer HealthCare LLC",NJ,100000005409,1350.00,04/09/2014,RSRCH,205837296
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1300.00,06/20/2014,GNRL,196536820
132783,RSRCH,"Bayer HealthCare LLC",NJ,100000005409,1080.00,09/22/2014,RSRCH,205830884
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,960.00,11/16/2014,GNRL,164830594
132783,GNRL,"Medrad Inc.",PA,100000005523,900.00,08/02/2013,GNRL,31065789
132783,GNRL,"LILLY USA, LLC",IN,100000000066,900.00,03/19/2014,GNRL,137690096
132783,GNRL,"Thoratec Corporation",CA,100000000296,829.84,10/04/2013,GNRL,103186810
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,810.00,03/05/2014,GNRL,187792876
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,810.00,02/21/2014,GNRL,187779906
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,810.00,06/11/2014,GNRL,187920274
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,810.00,05/06/2014,GNRL,187878120
132783,RSRCH,"Bayer HealthCare LLC",NJ,100000005409,810.00,12/02/2014,RSRCH,205821796
132783,RSRCH,"Bayer HealthCare LLC",NJ,100000005409,810.00,09/22/2014,RSRCH,205830100
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,686.64,05/03/2014,GNRL,164853836
132783,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,622.69,08/22/2013,GNRL,101617588
132783,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,600.00,12/15/2015,GNRL,263310378
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,593.23,12/10/2014,GNRL,153121586
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,12/10/2013,GNRL,13990607
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,11/04/2013,GNRL,13990610
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,11/22/2013,GNRL,13990603
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,11/26/2013,GNRL,13990609
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,12/10/2013,GNRL,13990604
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,10/14/2013,GNRL,13990608
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,11/07/2013,GNRL,13990605
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,10/03/2013,GNRL,13990601
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,09/27/2013,GNRL,13990602
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,11/25/2013,GNRL,13990606
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,575.38,10/17/2015,GNRL,313991328
132783,RSRCH,"Bayer HealthCare LLC",NJ,100000005409,540.00,12/02/2014,RSRCH,205830154
132783,GNRL,"Edwards Lifesciences Corporation",CA,100000010633,523.76,03/21/2014,GNRL,209055292
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,521.08,05/30/2014,GNRL,196536936
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,500.00,11/18/2014,GNRL,196536930
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,500.00,09/23/2014,GNRL,196536940
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,500.00,08/28/2014,GNRL,196536946
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,500.00,11/17/2014,GNRL,196536808
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,500.00,09/22/2014,GNRL,196536938
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,500.00,09/11/2014,GNRL,196536944
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,471.70,09/25/2015,GNRL,290626522
132783,GNRL,"LILLY USA, LLC",IN,100000000066,450.00,12/27/2013,GNRL,100180834
132783,GNRL,"LILLY USA, LLC",IN,100000000066,450.00,08/23/2013,GNRL,100181974
132783,GNRL,"LILLY USA, LLC",IN,100000000066,450.00,11/10/2014,GNRL,137697564
132783,GNRL,"LILLY USA, LLC",IN,100000000066,450.00,12/12/2014,GNRL,137695376
132783,GNRL,"Thoratec Corporation",CA,100000000296,449.27,10/04/2013,GNRL,103186808
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,431.25,04/07/2015,GNRL,246017530
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,426.89,12/10/2014,GNRL,153121582
132783,GNRL,"Edwards Lifesciences Corporation",CA,100000010633,424.70,03/13/2014,GNRL,209061606
132783,RSRCH,"Bayer HealthCare LLC",NJ,100000005409,405.00,12/02/2014,RSRCH,205822566
132783,GNRL,"Medrad Inc.",PA,100000005523,400.00,08/02/2013,GNRL,31048256
132783,GNRL,"Medrad Inc.",PA,100000005523,400.00,08/02/2013,GNRL,31071952
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,08/14/2013,GNRL,104477520
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,08/22/2013,GNRL,104477522
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,09/17/2013,GNRL,104477526
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,09/19/2013,GNRL,104477530
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,08/20/2013,GNRL,104477524
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,10/17/2013,GNRL,104477534
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,11/22/2013,GNRL,104477536
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,09/25/2013,GNRL,104477528
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,10/15/2013,GNRL,104477532
132783,GNRL,"The Medicines Company",NJ,100000010428,346.19,10/11/2015,GNRL,337737766
132783,GNRL,"Edwards Lifesciences Corporation",CA,100000010633,337.02,03/21/2014,GNRL,209043464
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,320.42,05/30/2014,GNRL,196536934
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,306.90,04/07/2015,GNRL,246017528
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,300.52,02/25/2015,GNRL,260125204
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,300.00,02/03/2015,GNRL,260113640
132783,GNRL,"LILLY USA, LLC",IN,100000000066,269.00,12/23/2013,GNRL,100181740
132783,GNRL,"Covidien Sales LLC",MA,100000000098,251.28,10/27/2013,GNRL,31676395
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,250.00,08/20/2013,GNRL,14016068
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,250.00,02/04/2014,GNRL,164552624
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,250.00,01/10/2014,GNRL,164552620
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,250.00,10/08/2014,GNRL,164830596
132783,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,200.00,02/19/2014,GNRL,147742062
132783,GNRL,"Cardiovascular Systems Inc.",MN,100000000117,190.09,02/23/2015,GNRL,318310482
132783,GNRL,"LILLY USA, LLC",IN,100000000066,186.94,12/23/2013,GNRL,100181978
132783,GNRL,"AngioDynamics, Inc.",NY,100000005504,175.88,08/22/2014,GNRL,192798130
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,168.37,09/25/2015,GNRL,290626524
132783,GNRL,"Biocompatibles, Inc.",CT,100000011081,167.72,10/10/2014,GNRL,220827968
132783,GNRL,"Edwards Lifesciences Corporation",CA,100000010633,152.48,03/11/2014,GNRL,209064872
132783,GNRL,"Edwards Lifesciences Corporation",CA,100000010633,144.00,03/14/2014,GNRL,209043042
132783,GNRL,"AngioDynamics, Inc.",NY,100000005504,143.84,01/14/2015,GNRL,275731600
132783,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,143.42,10/10/2014,GNRL,215162210
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,140.74,07/17/2014,GNRL,153121632
132783,GNRL,"Edwards Lifesciences Corporation",CA,100000010633,132.60,03/13/2014,GNRL,209058516
132783,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,132.37,11/12/2013,GNRL,100742918
132783,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,130.91,07/23/2015,GNRL,317653780
132783,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,128.93,09/20/2013,GNRL,101619266
132783,GNRL,"Medtronic Vascular, Inc.",MN,100000010384,128.53,09/21/2013,GNRL,101395618
132783,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,125.57,11/12/2015,GNRL,317664222
132783,GNRL,"Edwards Lifesciences Corporation",CA,100000010633,125.42,11/19/2013,GNRL,28831661
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,125.00,05/30/2014,GNRL,196536822
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,124.13,10/11/2015,GNRL,246017560
132783,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,117.65,06/18/2015,GNRL,317651662
132783,GNRL,"Covidien Sales LLC",MA,100000000098,112.86,10/24/2014,GNRL,222035940
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,112.46,02/17/2015,GNRL,332356463
132783,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,109.68,05/28/2015,GNRL,317649972
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,109.10,11/16/2014,GNRL,168754494
132783,GNRL,"Edwards Lifesciences Corporation",CA,100000010633,108.70,09/16/2014,GNRL,209086656
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,107.92,02/17/2015,GNRL,332356453
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,106.13,10/17/2015,GNRL,316682422
132783,GNRL,"Thoratec Corporation",CA,100000000296,106.05,06/02/2015,GNRL,263748064
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,105.92,10/27/2015,GNRL,246017572
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,105.85,11/10/2015,GNRL,290626516
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,105.81,09/08/2014,GNRL,196011848
132783,GNRL,"Cardiovascular Systems Inc.",MN,100000000117,104.94,07/15/2015,GNRL,318245128
132783,GNRL,"BOSTON SCIENTIFIC CORPORATION",MA,100000005674,102.29,11/11/2014,GNRL,227711002
132783,GNRL,"AngioScore, Inc.",CA,100000010429,102.16,10/29/2013,GNRL,102477196
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,101.68,12/17/2013,GNRL,104467782
132783,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,101.60,07/07/2015,GNRL,330667375
132783,GNRL,"St. Jude Medical, Inc.",MN,100000000310,101.09,12/09/2013,GNRL,100604578
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,100.00,01/17/2014,GNRL,148928324
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,99.52,11/21/2013,GNRL,12205224
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,99.51,07/28/2014,GNRL,168754475
132783,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,99.20,11/25/2015,GNRL,326307612
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,98.87,07/23/2014,GNRL,196536814
132783,GNRL,"Bayer HealthCare LLC",NJ,100000005409,98.16,04/01/2014,GNRL,218956204
132783,GNRL,"Abbott Laboratories",IL,100000010680,96.77,09/14/2014,GNRL,195943246
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,96.06,06/16/2015,GNRL,290626526
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,94.98,06/20/2014,GNRL,196536816
132783,GNRL,"GENZYME CORPORATION",MA,100000000297,94.86,04/07/2014,GNRL,188523106
132783,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,93.96,11/18/2015,GNRL,263310384
132783,GNRL,"Bayer HealthCare LLC",NJ,100000005409,93.61,10/22/2013,GNRL,31064516
132783,GNRL,"The Medicines Company",NJ,100000010428,93.53,07/24/2014,GNRL,211978930
132783,GNRL,"LILLY USA, LLC",IN,100000000066,93.19,10/21/2013,GNRL,100180842
132783,GNRL,"Abbott Laboratories",IL,100000010680,93.15,06/09/2015,GNRL,332938996
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,92.93,05/08/2014,GNRL,148754632
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,92.02,09/17/2015,GNRL,316682416
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,91.97,10/08/2015,GNRL,316682418
132783,GNRL,"Covidien Sales LLC",MA,100000000098,90.88,12/31/2013,GNRL,31676398
132783,GNRL,"Bayer HealthCare LLC",NJ,100000005409,90.81,10/30/2013,GNRL,31072894
132783,GNRL,"Pfizer Inc.",NY,100000000286,90.27,10/29/2014,GNRL,207098458
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,88.86,11/20/2013,GNRL,104464782
132783,GNRL,"Covidien Sales LLC",MA,100000000098,87.16,09/24/2013,GNRL,31676394
132783,GNRL,"Bayer HealthCare LLC",NJ,100000005409,86.86,05/14/2014,GNRL,219012268
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,85.69,11/18/2014,GNRL,168754478
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,84.67,05/20/2015,GNRL,260126526
132783,GNRL,"Cardiovascular Systems Inc.",MN,100000000117,84.62,03/04/2015,GNRL,318259708
132783,GNRL,"Thoratec Corporation",CA,100000000296,84.60,07/09/2015,GNRL,263748066
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,84.52,06/09/2015,GNRL,246017542
132783,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,84.10,02/18/2015,GNRL,331204221
132783,GNRL,"St. Jude Medical, Inc.",MN,100000000310,83.70,01/13/2014,GNRL,164817722
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,82.74,09/25/2015,GNRL,290626508
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,82.58,04/14/2015,GNRL,332297045
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,82.05,04/16/2015,GNRL,246017534
132783,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,81.99,10/01/2014,GNRL,215160952
132783,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,81.99,10/01/2014,GNRL,215160948
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,81.29,07/27/2015,GNRL,246017520
132783,GNRL,"Cordis Corporation",CA,100000005411,80.57,06/02/2014,GNRL,120486081
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,79.80,09/08/2014,GNRL,196536798
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,79.47,09/29/2015,GNRL,246017568
132783,GNRL,"Medtronic Vascular, Inc.",MN,100000010384,78.75,08/12/2013,GNRL,101395614
132783,GNRL,"Abbott Laboratories",IL,100000010680,78.18,10/12/2014,GNRL,195947952
132783,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,77.94,06/11/2015,GNRL,263310374
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,77.81,02/18/2014,GNRL,164853834
132783,GNRL,"Medtronic Vascular, Inc.",MN,100000010384,77.02,11/19/2015,GNRL,296297382
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,76.66,12/09/2014,GNRL,153121617
132783,GNRL,"Pfizer Inc.",NY,100000000286,76.47,10/11/2013,GNRL,205076438
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,76.18,08/26/2014,GNRL,188044346
132783,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,75.79,11/04/2015,GNRL,263310380
132783,GNRL,"Edwards Lifesciences Corporation",CA,100000010633,75.40,05/29/2014,GNRL,209069572
132783,GNRL,"Medtronic Vascular, Inc.",MN,100000010384,73.86,10/28/2013,GNRL,101395612
132783,GNRL,"EMD Serono, Inc.",MA,100000000127,72.96,07/23/2014,GNRL,209083052
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,70.09,10/15/2014,GNRL,153121693
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,69.51,01/07/2015,GNRL,332309627
132783,GNRL,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,69.33,08/25/2015,GNRL,321527749
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,69.00,05/31/2014,GNRL,196536926
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,68.50,04/08/2015,GNRL,246017536
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,67.61,11/16/2015,GNRL,246017516
132783,GNRL,"LILLY USA, LLC",IN,100000000066,67.40,09/25/2013,GNRL,100161862
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,65.30,02/25/2015,GNRL,260124902
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,65.03,04/14/2015,GNRL,332297021
132783,GNRL,"St. Jude Medical, Inc.",MN,100000000310,64.89,03/09/2015,GNRL,259521018
132783,GNRL,"ZOLL Lifecor Corporation",PA,100000000178,64.60,10/10/2013,GNRL,103996434
132783,GNRL,"Pfizer Inc.",NY,100000000286,64.58,10/24/2014,GNRL,207098462
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,64.21,12/12/2013,GNRL,102129486
132783,GNRL,"Bayer HealthCare LLC",NJ,100000005409,64.09,08/06/2014,GNRL,219052964
132783,GNRL,ABIOMED,MA,100000010740,64.06,08/04/2015,GNRL,337563260
132783,GNRL,"Thoratec Corporation",CA,100000000296,64.00,11/04/2013,GNRL,103186806
132783,GNRL,"Pfizer Inc.",NY,100000000286,61.72,10/18/2013,GNRL,206077818
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,61.22,02/18/2014,GNRL,168754490
132783,GNRL,"Covidien Sales LLC",MA,100000000098,60.57,01/19/2014,GNRL,222035936
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,60.43,05/03/2014,GNRL,168754488
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,59.19,09/16/2014,GNRL,153121680
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,58.19,02/09/2014,GNRL,168754468
132783,GNRL,"Lantheus Medical Imaging, Inc.",MA,100000005400,58.06,03/05/2014,GNRL,182165486
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,57.57,12/10/2014,GNRL,153121590
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,51.98,10/14/2014,GNRL,153121686
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,51.59,07/29/2014,GNRL,196536942
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,50.00,04/25/2015,GNRL,316682412
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,49.66,11/20/2013,GNRL,104460112
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,49.54,05/03/2014,GNRL,168754482
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,49.40,02/09/2014,GNRL,168754471
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,48.22,10/17/2015,GNRL,316682420
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,48.18,04/25/2015,GNRL,316682414
132783,GNRL,"Pfizer Inc.",NY,100000000286,47.28,10/22/2013,GNRL,206077806
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,47.24,10/28/2013,GNRL,102129484
132783,GNRL,"EKOS Corporation",WA,100000011032,46.60,12/02/2013,GNRL,105370554
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,46.59,10/17/2015,GNRL,316682426
132783,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,46.35,12/14/2015,GNRL,263310368
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,46.31,07/15/2014,GNRL,196536802
132783,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,46.00,02/11/2015,GNRL,317639956
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,45.83,07/15/2014,GNRL,196536806
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,45.20,09/23/2013,GNRL,12209496
132783,GNRL,"Cardiovascular Systems Inc.",MN,100000000117,44.46,09/23/2013,GNRL,101762124
132783,GNRL,"Edwards Lifesciences Corporation",CA,100000010633,43.57,04/01/2014,GNRL,209064692
132783,GNRL,"Bayer HealthCare LLC",NJ,100000005409,42.80,09/19/2013,GNRL,31076239
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,42.26,09/25/2015,GNRL,290626506
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,40.00,05/31/2014,GNRL,196536916
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,40.00,02/25/2015,GNRL,260120416
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,40.00,09/26/2015,GNRL,290626502
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,40.00,09/26/2015,GNRL,290626514
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,36.81,05/31/2014,GNRL,196536928
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,35.00,09/26/2015,GNRL,290626534
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,34.99,05/31/2014,GNRL,196536824
132783,GNRL,"LILLY USA, LLC",IN,100000000066,32.28,12/23/2013,GNRL,100180868
132783,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,31.51,03/06/2014,GNRL,216397558
132783,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,30.05,11/04/2015,GNRL,263310376
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,29.99,09/26/2015,GNRL,290626530
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,29.65,04/07/2015,GNRL,246017526
132783,GNRL,"Edwards Lifesciences Corporation",CA,100000010633,27.61,12/14/2015,GNRL,310754084
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,27.49,10/16/2014,GNRL,153121699
132783,GNRL,"Medtronic Vascular, Inc.",MN,100000010384,26.67,12/19/2013,GNRL,101395620
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,26.25,10/28/2015,GNRL,246017574
132783,GNRL,"Regeneron Healthcare Solutions, Inc.",NY,100000136416,25.76,07/30/2015,GNRL,321524884
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,24.99,05/31/2014,GNRL,196536914
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,24.99,05/31/2014,GNRL,196536826
132783,GNRL,"Gilead Sciences Inc",CA,100000000108,24.68,09/10/2015,GNRL,316682424
132783,GNRL,"Cordis Corporation",CA,100000005411,22.16,10/07/2013,GNRL,10402253
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,21.92,02/06/2014,GNRL,149097264
132783,GNRL,"Cordis Corporation",CA,100000005411,21.70,11/07/2013,GNRL,10403306
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,21.40,09/30/2014,GNRL,153121704
132783,GNRL,"Cordis Corporation",CA,100000005411,21.37,08/28/2013,GNRL,10401450
132783,GNRL,"LILLY USA, LLC",IN,100000000066,21.20,12/23/2013,GNRL,100180866
132783,GNRL,"Bayer HealthCare LLC",NJ,100000005409,19.88,10/23/2013,GNRL,31071002
132783,GNRL,"Bayer HealthCare LLC",NJ,100000005409,19.88,10/23/2013,GNRL,31058491
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,19.81,09/26/2015,GNRL,290626504
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.56,02/19/2014,GNRL,187777448
132783,GNRL,"Cook Incorporated",IN,100000010458,19.23,12/04/2013,GNRL,210737320
132783,GNRL,"Bayer HealthCare LLC",NJ,100000005409,19.07,04/02/2014,GNRL,218959514
132783,GNRL,"Medtronic Vascular, Inc.",MN,100000010384,19.06,01/12/2015,GNRL,296920142
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,18.00,10/12/2015,GNRL,246017564
132783,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,17.94,11/19/2013,GNRL,105126726
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.94,12/01/2015,GNRL,290626532
132783,GNRL,"Edwards Lifesciences Corporation",CA,100000010633,17.85,06/17/2014,GNRL,209052542
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,17.40,12/10/2014,GNRL,153121626
132783,GNRL,"Edwards Lifesciences Corporation",CA,100000010633,17.29,06/08/2015,GNRL,310639929
132783,GNRL,"BOSTON SCIENTIFIC CORPORATION",MA,100000005674,16.81,11/13/2014,GNRL,227711004
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,16.76,12/10/2014,GNRL,153121622
132783,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,16.56,10/17/2013,GNRL,105126724
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.29,08/06/2013,GNRL,12205369
132783,GNRL,"Cardiovascular Systems Inc.",MN,100000000117,16.24,12/10/2013,GNRL,101766826
132783,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,16.14,11/20/2013,GNRL,101622902
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.01,03/24/2015,GNRL,260066574
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.89,10/29/2014,GNRL,196536932
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,15.58,09/30/2015,GNRL,246017570
132783,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,15.50,02/19/2014,GNRL,199573690
132783,GNRL,"Covidien Sales LLC",MA,100000000098,15.40,09/18/2013,GNRL,31676396
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.31,09/23/2013,GNRL,174056110
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.21,03/04/2014,GNRL,149343560
132783,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,15.20,11/10/2015,GNRL,263310388
132783,GNRL,"AngioDynamics, Inc.",NY,100000005504,14.07,01/23/2015,GNRL,270276218
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,14.06,06/10/2015,GNRL,246017544
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.62,06/20/2014,GNRL,196536800
132783,GNRL,"Bayer HealthCare LLC",NJ,100000005409,13.61,09/11/2013,GNRL,31073594
132783,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,13.15,10/22/2014,GNRL,199573686
132783,GNRL,"Lantheus Medical Imaging, Inc.",MA,100000005400,12.60,12/15/2015,GNRL,265077696
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.59,11/21/2013,GNRL,12192835
132783,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.55,09/14/2015,GNRL,337328214
132783,GNRL,"Pfizer Inc.",NY,100000000286,12.49,10/03/2013,GNRL,205206612
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.28,06/11/2014,GNRL,196536912
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.13,11/09/2015,GNRL,290140358
132783,GNRL,"Medtronic Vascular, Inc.",MN,100000010384,12.11,09/21/2013,GNRL,101395616
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.91,11/21/2013,GNRL,12288160
132783,GNRL,"Medtronic Vascular, Inc.",MN,100000010384,11.64,02/17/2015,GNRL,296920144
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,11.59,10/05/2015,GNRL,246017552
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.57,09/16/2013,GNRL,12260694
132783,GNRL,"Pfizer Inc.",NY,100000000286,11.55,11/07/2014,GNRL,206855630
132783,GNRL,"Pfizer Inc.",NY,100000000286,11.43,11/19/2013,GNRL,205662126
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,11.42,03/11/2015,GNRL,246017532
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,10.60,09/16/2015,GNRL,246017556
132783,GNRL,"Lantheus Medical Imaging, Inc.",MA,100000005400,10.50,08/23/2013,GNRL,101635330
132783,GNRL,"Covidien Sales LLC",MA,100000000098,10.49,09/10/2014,GNRL,222035938
132783,GNRL,"Cordis Corporation",CA,100000005411,10.46,04/01/2015,GNRL,247139596
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.00,02/13/2014,GNRL,148305652
132783,GNRL,"The Medicines Company",NJ,100000010428,9.99,08/06/2015,GNRL,337737734
132783,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,8.82,11/12/2013,GNRL,100742916
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,8.63,09/16/2013,GNRL,12288159
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,8.36,11/24/2015,GNRL,246017512
132783,GNRL,"LILLY USA, LLC",IN,100000000066,8.00,12/23/2013,GNRL,100180836
132783,GNRL,"Cardiovascular Systems Inc.",MN,100000000117,7.63,07/23/2014,GNRL,204284374
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,7.50,06/04/2014,GNRL,153121674
132783,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,7.25,12/14/2015,GNRL,263310372
132783,GNRL,"Pfizer Inc.",NY,100000000286,6.78,10/03/2013,GNRL,205206614
132783,GNRL,"AngioScore, Inc.",CA,100000010429,6.33,12/11/2013,GNRL,102477194
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,6.00,05/14/2014,GNRL,153121668
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,6.00,08/25/2014,GNRL,153121636
132783,GNRL,"The Medicines Company",NJ,100000010428,5.16,08/25/2015,GNRL,337737736
132783,GNRL,"LILLY USA, LLC",IN,100000000066,5.00,12/23/2013,GNRL,100181976
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,5.00,04/11/2014,GNRL,153121646
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,5.00,04/24/2014,GNRL,153121651
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,5.00,04/25/2014,GNRL,153121656
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,5.00,03/05/2014,GNRL,153121642
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,5.00,05/01/2014,GNRL,153121662
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,5.00,11/21/2014,GNRL,153121612
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,5.00,11/03/2015,GNRL,246017514
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,4.41,08/07/2013,GNRL,14016070
132783,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,4.41,08/07/2013,GNRL,14016069
132783,GNRL,"Cordis Corporation",CA,100000005411,3.91,01/14/2015,GNRL,247137324
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,3.47,08/26/2015,GNRL,246017518
132783,GNRL,"Boston Scientific Corporation",MA,100000005674,2.46,06/02/2015,GNRL,246017540
132783,GNRL,"Bayer HealthCare LLC",NJ,100000005409,2.31,09/11/2013,GNRL,31072042
132783,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.31,12/02/2015,GNRL,331116649
132783,GNRL,"Cardiovascular Systems Inc.",MN,100000000117,1.94,09/25/2013,GNRL,101762324
132783,GNRL,"Bayer HealthCare LLC",NJ,100000005409,1.89,09/11/2013,GNRL,31058311
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.88,04/01/2014,GNRL,196536920
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.88,04/01/2014,GNRL,196536918
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.88,04/01/2014,GNRL,196536922
132783,GNRL,"Cardiovascular Systems Inc.",MN,100000000117,1.86,12/16/2013,GNRL,101759012
132783,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.48,11/17/2015,GNRL,290626512
132783,GNRL,"Bayer HealthCare LLC",NJ,100000005409,1.42,09/11/2013,GNRL,31075061
132783,GNRL,"Cardiovascular Systems Inc.",MN,100000000117,1.33,12/18/2013,GNRL,101759082
132783,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,0.62,09/23/2013,GNRL,174059024
